As negotiations towards a new pandemic treaty pick up pace, observers warn of watered-down efforts to ensure equitable access to the medical products needed to battle future COVID-like threats.
Shaken by the pandemic, the WHO’s 194 member states are negotiating an international accord aimed at ensuring countries are better equipped to deal with the next catastrophe, or even prevent it altogether.
The process is still in the early stages, with the aim of reaching an agreement by May next year.
Photo: EPA-EFE
But critics warn that revisions being made to the preliminary negotiating text are weakening the language — notably in a key area aimed at preventing the rampant inequity seen in access to vaccines and other medical products during the COVID pandemic.
“I think it is a real step backwards,” said Suerie Moon, co-director of the Global Health Center at the Geneva Graduate Institute.
If poorer nations do not see solid language ensuring they will be better protected when the next pandemic hits, “there is a real risk that countries will walk away” from the talks, she warned.
‘NOT GOOD ENOUGH’
Observers said the new draft, which will be considered during the next round of negotiations led by the Intergovernmental Negotiating Body (INB) in mid-June, was “cleaner” — but also weaker on some major points. In particular, public interest groups said the removal of a call for public funds given to private sector R&D to be conditional on more transparent pricing of their products was an issue.
Instead, the updated draft urges countries to strive to promote knowledge-sharing and transparency “in accordance with national laws and as appropriate.”
Countries should also “incentivize manufacturers of pandemic-related products to transfer relevant technology and know-how” to lower-income countries, one option says.
“Voluntary measures are not good enough,” Luis Villarroel, head of the Innovarte NGO, which is focused on ensuring a balanced intellectual property system.
The text is “very weak,” he told reporters.
URGENCY
There are also elements in the text that will likely not sit well with the pharmaceutical industry. They include the option to link the sharing of pathogen samples with a requirement to share the benefits from the resulting products.
While agreeing it is important for all countries to swiftly share samples of viruses and bacteria that could cause dangerous outbreaks, poorer countries want access to the benefits, including the vaccines produced, technology transfers, royalties or capacity building programs.
The International Federation of Pharmaceutical Manufacturers and Associations has warned that linking access to pathogen samples with such benefit sharing could dangerously slow down the sharing of vital data.
“We remain concerned that decisions could be taken that we come to regret,” IFPMA chief Thomas Cueni said.
“The innovation system and rapid access to pathogens were both crucial in enabling the pharmaceutical industry to develop new vaccines, treatments and diagnostics in response to COVID-19.”
One thing everyone seems to agree on is that new pandemic threats are looming, and there is urgency in aligning positions to meet the May deadline next year.
“I think we’ll get an accord in place if everyone realizes that our window before this next pandemic, this next health threat, is probably not far away,” US Health and Human Services Secretary Xavier Becerra told journalists in Geneva last week.
In late October of 1873 the government of Japan decided against sending a military expedition to Korea to force that nation to open trade relations. Across the government supporters of the expedition resigned immediately. The spectacle of revolt by disaffected samurai began to loom over Japanese politics. In January of 1874 disaffected samurai attacked a senior minister in Tokyo. A month later, a group of pro-Korea expedition and anti-foreign elements from Saga prefecture in Kyushu revolted, driven in part by high food prices stemming from poor harvests. Their leader, according to Edward Drea’s classic Japan’s Imperial Army, was a samurai
Located down a sideroad in old Wanhua District (萬華區), Waley Art (水谷藝術) has an established reputation for curating some of the more provocative indie art exhibitions in Taipei. And this month is no exception. Beyond the innocuous facade of a shophouse, the full three stories of the gallery space (including the basement) have been taken over by photographs, installation videos and abstract images courtesy of two creatives who hail from the opposite ends of the earth, Taiwan’s Hsu Yi-ting (許懿婷) and Germany’s Benjamin Janzen. “In 2019, I had an art residency in Europe,” Hsu says. “I met Benjamin in the lobby
April 22 to April 28 The true identity of the mastermind behind the Demon Gang (魔鬼黨) was undoubtedly on the minds of countless schoolchildren in late 1958. In the days leading up to the big reveal, more than 10,000 guesses were sent to Ta Hwa Publishing Co (大華文化社) for a chance to win prizes. The smash success of the comic series Great Battle Against the Demon Gang (大戰魔鬼黨) came as a surprise to author Yeh Hung-chia (葉宏甲), who had long given up on his dream after being jailed for 10 months in 1947 over political cartoons. Protagonist
A fossil jawbone found by a British girl and her father on a beach in Somerset, England belongs to a gigantic marine reptile dating to 202 million years ago that appears to have been among the largest animals ever on Earth. Researchers said on Wednesday the bone, called a surangular, was from a type of ocean-going reptile called an ichthyosaur. Based on its dimensions compared to the same bone in closely related ichthyosaurs, the researchers estimated that the Triassic Period creature, which they named Ichthyotitan severnensis, was between 22-26 meters long. That would make it perhaps the largest-known marine reptile and would